MI
KWON KIM
Profesor asociado de Ciencias de la Salud
CARLOS JAVIER
ANGUITA VELASCO
Profesor asociado de Ciencias de la Salud
CARLOS JAVIER ANGUITA VELASCO-rekin lankidetzan egindako argitalpenak (33)
2024
-
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy
Blood transfusion = Trasfusione del sangue, Vol. 22, Núm. 3, pp. 239-245
-
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12
-
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation
Frontiers in Immunology, Vol. 15
2023
-
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Annals of Hematology, Vol. 102, Núm. 6, pp. 1561-1567
-
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
Frontiers in immunology, Vol. 14, pp. 1165759
2022
-
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
Frontiers in immunology, Vol. 13, pp. 1002959
-
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 16
2021
-
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Frontiers in Immunology, Vol. 12
-
Next generation cytogenetics in myeloid hematological neoplasms: Detection of cnvs and translocations
Cancers, Vol. 13, Núm. 12
-
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
Annals of Hematology, Vol. 100, Núm. 2, pp. 541-553
2020
-
Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma
Bone Marrow Transplantation, Vol. 55, Núm. 9, pp. 1716-1725
-
Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide
Hematological Oncology, Vol. 38, Núm. 4, pp. 597-603
-
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 11, pp. 2089-2097
2019
-
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders
AIDS, Vol. 33, Núm. 9, pp. 1441-1447
-
Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center
Journal of Clinical Apheresis, Vol. 34, Núm. 4, pp. 373-380
-
Mononuclear cell collection for extracorporeal photopheresis by using the “off-line” system: A comparative study between COBE Spectra and Spectra Optia devices
Journal of Clinical Apheresis, Vol. 34, Núm. 4, pp. 359-366
-
Next-generation sequencing improves diagnosis, prognosis and clinical management of myeloid neoplasms
Cancers, Vol. 11, Núm. 9
-
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation
Blood Advances, Vol. 3, Núm. 21, pp. 3351-3359